FTC starts intensive inspection about patent license on 71 pharmas

The FTC will intensively inspect the custom related to patent license in the pharmaceutical industry, such as pay-for-delay, on 71 pharmaceutical companies in Korea.

The Fair Trade Commission(FTC) announced on the 26^th that it will start an inspection of situation about the patent license custom in the pharmaceutical and biotechnology fields.

The FTC criticized “Abuse of patent, such as pay-f...